Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys

Neuroscience

• Morphine 100%
• Memory 60%
• Receptor Antagonist 40%
• Opioid 40%
• Phencyclidine 40%
• Scopolamine 40%
• Sucrose 40%
• μ-Opioid Receptor 40%
• Mu Opiate Receptor 40%
• Opioid Abuse 40%
• Depression 20%
• Muscarinic Acetylcholine Receptor 20%
• δ -Opioid Receptor 20%
• Aspartic Acid 20%
• Decision-Making 20%
• Adverse Effect 20%
• Behavior (Neuroscience) 20%
• Cognition 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Morphine 100%
• Opiate 80%
• Rhesus Monkey 40%
• Phencyclidine 40%
• Sucrose 40%
• Scopolamine 40%
• Toxic Injury 20%
• Opiate Receptor 20%
• Adverse Event 20%
• Respiration Depression 20%
• Aspartic Acid 20%
• Muscarinic Receptor Blocking Agent 20%
• Antagonist 20%
• Mu Opiate Receptor Antagonist 20%
• Mu Opiate Receptor 20%